ReviewJournal of the Endocrine Society2026
Personalization of incretin therapy: can GLP-1 and GIP receptor polymorphisms influence therapy response?
Sandro La Vignera et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it